You just read:

BioLineRx Signs Second Clinical Immuno-Oncology Collaboration Agreement to Investigate Combination of BL-8040 and KEYTRUDA® for Pancreatic Cancer

News provided by

BioLineRx Ltd.

Aug 08, 2016, 07:00 ET